SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organization. Disability Prevention and Rehabilitation. Technical Report Series No. 668. Geneva: WHO 1981.
  • 2
    Mishra S, Singh PC, Mishra M. Metronidazole in management of trophic ulcers in leprosy. Indian J Dermatol Venereol Leprol 1995; 61: 1920.
  • 3
    Bhatt YC, Panse NS, Vyas KA, et al. Free tissue transfer for trophic ulcer complicating leprosy. Indian J Plast Surg 2009; 42: 115117.
  • 4
    Puri V, Venkateshwaran N, Khare N. Trophic ulcers. Practical management guidelines. Indian J Plast Surg 2012; 45: 340351.
  • 5
    Kimball OP, Horan TN. The use of dilantin in the treatment of epilepsy. Ann Intern Med 1939; 13: 787793.
  • 6
    Shapiro M. Acceleration of gingival wound healing in non-epileptic patients receiving diphenylhydantoin sodium (dilantin, epanutin). Exp Med Surg 1958; 16: 4153.
  • 7
    Shafer WG, Beatty RE, Davis WB. Effect of dilantin sodium on tensile strength of healing wounds. Proc Soc Exp Biol Med 1958; 98: 348350.
  • 8
    Shafer WG. Effect of dilantin sodium on various cell lines in tissue cultures. Proc Soc Exp Biol Med 1961; 108: 694696.
  • 9
    El Zayat SG. Preliminary experience with topical phenytoin in wound healing in a war zone. Mil Med 1989; 154: 178180.
  • 10
    Modaghegh S, Salehian B, Tavassoli M. Use of topical phenytoin in healing of war and non-war wounds. A pilot study of 25 cases. Int J Dermatol 1989; 28: 347350.
  • 11
    Lodha SC, Lohiya ML, Vyas MC, et al. Role of phenytoin in healing large abscess cavities. Br J Surg 1991; 78: 105108.
  • 12
    Pendse AK, Sharma A, Sodani A, et al. Topical phenytoin in wound healing. Int J Dermatol 1993; 32: 214217.
  • 13
    Bhatia A, Prakash S. Topical phenytoin in wound healing. Dermatol Online J 2004; 10: 5.
  • 14
    Bansal NK, Mukul AK. Comparison of topical phenytoin with normal saline in the treatment of chronic trophic ulcers in leprosy. Int J Dermatol 1995; 32: 210213.
  • 15
    Menezes J, Rajendran A, Jacob AJ, et al. The use of topical phenytoin as an adjunct to immobilization in the treatment of trophic leprosy ulcers. Southeast Asian J Trop Med Public Health 1993; 24: 340342.
  • 16
    Bogaert H, Saleta B, Sanchez E, et al. Trophic leprosy ulcers: treatment with topical and systemic phenytoin. Int J Dermatol 1990; 29: 156157.
  • 17
    Oluwatosin OM, Olabanji JK, Oluwatosin OA, et al. A comparison of topical honey and phenytoin in the treatment of chronic leg ulcers. Afr J Med Sci 2000; 29: 3134.
  • 18
    Sehgal VN, Srivastava G, Aggarwal AK, et al. Non-insulin-dependent, type II diabetes mellitus-related dermatoses: part III. Skinmed 2011; 9: 367375; quiz 375–376.
  • 19
    Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966; 34: 255273.
  • 20
    Sehgal VN. A seven-group classification for institutional and field work. Lepr Rev 1989; 60: 75.
  • 21
    Nienhuis WA, van Brakel WH, Butlin CR, et al. Measuring impairment caused by leprosy: inter-tester reliability of the WHO disability grading system. Lepr Rev 2004; 75: 221232.
  • 22
    Sehgal VN. Deformities and disabilities in leprosy. In: Sehgal VN, ed. Textbook of Clinical Leprosy, 5th edn. Delhi: Jaypee Brothers, 2013: 7890.
  • 23
    Vijiyasingam SM, Dykes PJ, Marks R. Phenytoin has little effect on in vitro models of wound healing. Br J Dermatol 1991; 125: 136139.
  • 24
    Berth-Jones J. Topical therapy. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's Textbook of Dermatology, 8th edn. Chichester: Wiley Blackwell 2010; 73.2.
  • 25
    Balaraju DN, Srinivas CR, Mukhi SV. Modified Unna boot and pinch grafting for chronic non-healing venous leg ulcer. J Cutan Aesthet Surg 2008; 1: 2526.
  • 26
    Kuebel MA, Yeager VL, Taylor JJ. Effect of phenytoin and/or beta-aminopropionitrile on surgically induced periosteal wound. J Exp Pathol 1985; 2: 99109.